NCT05598632
Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry
StatusUnknown
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Start date changed from estimate of Nov 10, 2022 to Apr 18, 2023
- Enrollment target: 17000 to 22000
- Study sites: 0 to 1
- Study description expanded, about 6 words
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Composite of Stroke and Systemic Embolic Events (SEE)
Timeframe: At 12-month after recruiting
Secondary (4)
Major Bleeding Events
All-Cause Mortality
Cardiac Death
Hospitalization for heart failure
Sites
1 site in 1 country
- Fuwai Hospital, CAMS & PUMCBeijing, Beijing Municipality, China